Immunomic Therapeutics, Inc. SBIR Phase I Award, August 2014
A SBIR Phase I contract was awarded to Immunomic Therapeutics in August, 2014 for $333,981.0 USD from the U.S. Department of Health & Human Services.
Name
# Contributions
Last Contribution
Find more entities like Immunomic Therapeutics, Inc. SBIR Phase I Award, August 2014
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
